All Q2 FY26 results →

CH

CVS Health Corporation

Q2 FY26Health Care Providers and Services

CVS Health Corporation Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹93

Market cap₹1.2L Cr

P/E39.8

Updated29 May 2026

Read4 min read

What the Q2 FY26 call signalled

1 of 3 strong

RevenueModerate growth

MarginMargins steady

CapexCapex planned

The short version

- Commercial business showing strong growth across all parts, including fully insured, driven by disciplined pricing and innovative products (Page 13). - CVS Health remains confident in delivering mid-teens EPS CAGR through 2028.

From CVS Health Corporation's Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Moderate growth

Commercial business showing strong growth across all parts, including fully insured, driven by disciplined pricing and innovative products (Page 13).
2026 total revenues expected to be at least $405 billion, a 15% increase compared to the prior year quarter (Page 4).
Pharmacy & Consumer Wellness segment revenues remained consistent with prior year but same-store pharmacy sales grew over 3%, led by a nearly 7% increase in same-store prescription volumes (Page 4).
Oak Street Health showing progress with revenue growth contributing to Health Services segment which grew 11% year-over-year (Page 4).

2 more points from CVS Health Corporation's call on revenue

Create a free account to keep reading this call

Profitability & Margins

CVS Health remains confident in delivering mid-teens EPS CAGR through 2028.
Full-year 2026 adjusted EPS guidance increased to a range of $7.30 to $7.50, up from $7 to $7.20.
Adjusted operating income for 2026 is expected between $15.53 billion to $15.87 billion.
Health Care Benefits segment AOI guidance raised by $420 million to approximately $4 billion to $4.34 billion.
Pharmacy & Consumer Wellness segment AOI guidance increased by $90 million to at least $6.18 billion.
They expect a roughly 60-40 split of earnings between first and second half of 2026.
Strong earnings power at Aetna supports a pathway to target margins by 2028.

2 more points from CVS Health Corporation's call on margins

Create a free account to keep reading this call

See what CVS Health Corporation said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

CVS Health is making meaningful reinvestments across the enterprise, particularly in technology and AI.
The company is transitioning from a consumer-based health care company to a consumer-based health care technology company.
Investments focus on improving cost structure, operational efficiency, and accuracy through advanced analytics and AI.
There is emphasis on equipping colleagues with AI skills via AI academies launched across the enterprise.
Specific investments include enhancing member experience with better navigation, empowerment, and insights through digital tools.
The commercial business is seeing investments in product innovation such as better navigation, advocacy programs, and provider-payer partnerships to reduce friction.

2 more points from CVS Health Corporation's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

The company is focused on strengthening its balance sheet by reducing leverage.
Share repurchase programs are currently paused to prioritize leverage reduction.
No share repurchase is baked into the 2026 guidance, but the company will evaluate capital deployment opportunities later in the year.

2 more points from CVS Health Corporation's call on fundraising

Create a free account to keep reading this call

See what CVS Health Corporation said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Insights related to business outlook and pipeline include: - The commercial business has a strong pipeline for 2027, with continued growth expected. - Investments are being made in products focused on better navigation, advocacy, and provider-payer partnerships to enhance member experience. - Commercial book has 18 million members, indicating a significant base for future sales and retention.

2 more points from CVS Health Corporation's call on order book

Create a free account to keep reading this call

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

CVS Health Corporation and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were CVS Health Corporation Q2 FY26 results?

- Commercial business showing strong growth across all parts, including fully insured, driven by disciplined pricing and innovative products (Page 13). - CVS Health remains confident in delivering mid-teens EPS CAGR through 2028.

What is CVS Health Corporation share price analysis?

CVS Health Corporation currently shows a below-average growth signal. The stock trades at a P/E of 39.8 with a market cap of $118,623. Investors should review the full earnings analysis for detailed insights.

Is CVS Health Corporation planning capital expenditure?

- CVS Health is making meaningful reinvestments across the enterprise, particularly in technology and AI.

Keep CVS Health Corporation on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.